Brown Michael Jon 4
4 · DEXCOM INC · Filed Mar 10, 2026
Research Summary
AI-generated summary of this filing
DexCom EVP Michael Brown Receives RSUs; Shares Withheld
What Happened Michael Jon Brown, Executive Vice President and Chief Legal Officer of DexCom, received a grant of 39,019 restricted stock units (RSUs) on March 8, 2026 (reported as an award at $0.00). On the same date, 23,325 shares were withheld by the issuer to satisfy tax withholding obligations at a reported value of $68.10 per share, totaling $1,588,432. The withholding is reported as a disposition for tax purposes but, per the filing, does not represent an open-market sale by Mr. Brown.
Key Details
- Transaction date: March 8, 2026; filed March 10, 2026 (timely filing).
- Award: 39,019 RSUs granted (no cash purchase; fair value shown as $0.00 in the table).
- Tax withholding: 23,325 shares withheld at $68.10/share = $1,588,432 (issuer withholding, not a sale by the insider per footnote).
- Holdings noted in the filing include 77,603 unvested RSUs in total and 255 shares from the Amended and Restated 2015 Employee Stock Purchase Plan.
- Of the 77,603 unvested RSUs: 39,019 granted 3/8/2026 (vest through 3/8/2029), 19,948 granted 3/8/2025 (vest through 3/8/2028), 11,399 granted 3/8/2025 (vest through 3/8/2027), 7,237 granted 3/8/2024 (vest through 3/8/2027).
- Notable footnotes:
- F1: RSUs exempt from Section 16b-3; vest in three equal annual installments.
- F2: Withheld shares cover tax obligations and are not a sale by the reporting person.
- F3: Breakdown of unvested RSUs and additional ESPP shares included in reported holdings.
Context RSUs are awards that convert to shares upon vesting; this grant is a compensation award rather than a market purchase. Net settlement/withholding of shares to cover taxes is a routine administrative step and should not be read as an intention to liquidate holdings. The filing shows forthcoming vesting over multiple years, meaning the recipient will only receive shares as those RSUs vest.
Insider Transaction Report
- Award
Common Stock
[F1]2026-03-08+39,019→ 137,929 total - Tax Payment
Common Stock
[F2][F3]2026-03-08$68.10/sh−23,325$1,588,432→ 114,604 total
Footnotes (3)
- [F1]Represents a grant of restricted stock units (RSUs) that are exempt from Section 16b-3 and are subject to vesting in three equal annual installments from the date of grant. RSUs represent a contingent right to receive one share of DexCom, Inc. Common Stock.
- [F2]Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of RSUs and does not represent a sale by the Reporting Person.
- [F3]Included in this number are 77,603 unvested RSUs, 39,019 of which were granted on March 8, 2026 and shall vest through March 8, 2029, 19,948 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 11,399 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 7,237 of which were granted on March 8, 2024 and shall vest through March 8, 2027, and 255 additional shares acquired under the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan.